From: Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer
Characteristics | No. of Patients | No. of Deaths | MST (months) | P* |
---|---|---|---|---|
Total subjects Age (mean) | 167 | 60 | 0.339 | |
≤57 years | 68 | 27 | 21.2 | |
>57 years | 99 | 33 | 31.0 | |
Gender | 0.988 | |||
Male | 114 | 41 | 23.3 | |
Female | 53 | 19 | 28.9 | |
Ethnicity | 0.297 | |||
White | 117 | 45 | 28.8 | |
Non-White† | 50 | 15 | 19.1 | |
Smoke | 0.475 | |||
Never | 34 | 14 | 20.6 | |
Ever | 133 | 46 | 30.1 | |
Alcohol | 0.809 | |||
Never | 62 | 23 | 23.2 | |
Ever | 105 | 37 | 29.3 | |
Location | 0.069 | |||
Stomach | 118 | 36 | 24.3 | |
Esophagus | 25 | 13 | 27.2 | |
GEJ | 24 | 11 | 16.6 | |
Histology | 0.356 | |||
Intestinal | 118 | 45 | 28.1 | |
Signet ring | 49 | 15 | 24.6 | |
Differentiation | 0.694 | |||
Poor | 96 | 37 | 21.8 | |
Moderate-poor | 28 | 10 | 29.8 | |
Moderate-Well | 42 | 13 | 22.6 | |
Clinical Stage | < 0.001 | |||
I + II | 65 | 9 | 30.4 | |
III + IV | 101 | 51 | 22.7 | |
Metastasis | < 0.001 | |||
yes | 90 | 49 | 21.2 | |
no | 77 | 11 | 34.2 | |
Chemotherapy | < 0.001 | |||
yes | 121 | 54 | 26.3 | |
no | 46 | 6 | 10.4 | |
Surgery | < 0.001 | |||
yes | 63 | 11 | 39.2 | |
no | 104 | 49 | 18.4 |